GYNE-LOTRIMIN Drug Patent Profile
✉ Email this page to a colleague
When do Gyne-lotrimin patents expire, and when can generic versions of Gyne-lotrimin launch?
Gyne-lotrimin is a drug marketed by Bayer Healthcare Llc and is included in six NDAs.
The generic ingredient in GYNE-LOTRIMIN is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gyne-lotrimin
A generic version of GYNE-LOTRIMIN was approved as clotrimazole by P AND L on July 16th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GYNE-LOTRIMIN?
- What are the global sales for GYNE-LOTRIMIN?
- What is Average Wholesale Price for GYNE-LOTRIMIN?
Summary for GYNE-LOTRIMIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,204 |
| DailyMed Link: | GYNE-LOTRIMIN at DailyMed |
Recent Clinical Trials for GYNE-LOTRIMIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bayer | Phase 3 |
| Taro Pharmaceuticals USA | Phase 1 |
US Patents and Regulatory Information for GYNE-LOTRIMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare Llc | GYNE-LOTRIMIN | clotrimazole | CREAM;VAGINAL | 018052-002 | Nov 30, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bayer Healthcare Llc | GYNE-LOTRIMIN 3 | clotrimazole | TABLET;VAGINAL | 020525-001 | Jul 29, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bayer Healthcare Llc | GYNE-LOTRIMIN | clotrimazole | TABLET;VAGINAL | 017717-002 | Nov 30, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for GYNE-LOTRIMIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
